drugset / Trial / NCT00568555
Effects of Low Dose Naltrexone in Fibromyalgia
RandomizedCrossoverTriple-blindTreatment
Summary
Low Dose Naltrexone (LDN) has been reported anecdotally to reduce the symptoms of Fibromyalgia, a Chronic Multisystem Illness. The drug may work by regulating natural pain-reducing systems. In this study, we will administer both LDN and placebo to a small group of individuals with Fibromyalgia and Gulf War Syndrome, both Chronic Multisymptom Illnesses, to assess the drug's efficacy in treating the condition.
Timeline
- Start
- 2007-06
- Primary completion
- 2010-01
- Completion
- 2010-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Naltrexone | Small molecule | 3 mg | Oral |
| Subject | Naltrexone | Small molecule | 4.5 mg | Oral |